Enspryng Drug Interactions: 130 Major, 724 Moderate
Enspryng (Satralizumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Enspryng. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
The serum concentration of Abemaciclib can be decreased when it is combined with Satralizumab.
Level 1 evidence
Abiraterone
The serum concentration of Abiraterone can be decreased when it is combined with Satralizumab.
Level 1 evidence
Abrocitinib
The serum concentration of Abrocitinib can be decreased when it is combined with Satralizumab.
Level 1 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be decreased when it is combined with Satralizumab.
Level 1 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be decreased when it is combined with Satralizumab.
Level 1 evidence
Acetaminophen
The serum concentration of Acetaminophen can be decreased when it is combined with Satralizumab.
Level 1 evidence
Acetylsalicylic acid
The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Satralizumab.
Level 1 evidence
Acyclovir
The serum concentration of Acyclovir can be decreased when it is combined with Satralizumab.
Level 1 evidence
Adagrasib
The serum concentration of Adagrasib can be decreased when it is combined with Satralizumab.
Level 1 evidence
Aficamten
The serum concentration of Aficamten can be decreased when it is combined with Satralizumab.
Level 1 evidence
Albendazole
The serum concentration of Albendazole can be decreased when it is combined with Satralizumab.
Level 1 evidence
Alclometasone
The serum concentration of Alclometasone can be decreased when it is combined with Satralizumab.
Level 1 evidence
Enter your NPI to unlock 20 major interactions for Enspryng
Enspryng (Satralizumab) has 859 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Enspryng (Satralizumab) has 130 major, 724 moderate, and 5 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Enspryng. Always confirm against the full prescribing information.